Ferroportin: A new molecule for regulation of iron homeostasis;La ferroportine, une nouvelle molécule pour la régulation du métabolisme du fer

Hematologie

Volumn 10, Issue 6, 2004, Pages 453-463

  Goncalves, Ana ^a   Beaumont, Carole ^a  

^a INSERM   (France)

Author keywords

Ceruloplasmin; Ferroportin; Hemochromatosis; Hephaestin; Iron homeostasis

Indexed keywords

CERULOPLASMIN; CYSTEINE; FERRITIN; FERROPORTIN 1; HEME; HEPCIDIN; HEPHAESTIN; PROTEIN; UNCLASSIFIED DRUG;

BASOLATERAL MEMBRANE; CATABOLISM; CELL VACUOLE; DUODENUM; ERYTHROCYTE; GENE EXPRESSION; HEMOCHROMATOSIS; HEMOSTASIS; INTESTINE CELL; IRON BLOOD LEVEL; IRON METABOLISM; IRON OVERLOAD; IRON TRANSPORT; MACROPHAGE; OXIDATION; PHAGOCYTOSIS; PROTEIN FUNCTION; REVIEW; SYNCYTIOTROPHOBLAST;

EID: 13844292541     PISSN: 12647527     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Knutsan M, Wessling-Resnick M. Iron metabolism in the reticuloendothelial system. Crit Rev Biochem Mol Biol 2003; 38: 61-88.
2. Andrews NC. Disorders of iron metabolism. N Engl J Med 1999; 341: 1986-95.
3. McKie AT, Marciani P, Rolfs A, et al. A navel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell 2000; 5: 299-309.
4. Abboud S, Haile DJ. A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J Biol Chem 2000; 275: 19906-12.
5. Donovan A, Brownlie A, Zhou Y, et al. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 2000; 403: 776-81.
6. McKie AT, Barrow D, Latunde-Dada GO, et al. An iron-regulated ferric reductase associated with the absorption of dietary iron. Science 2001; 291: 1755-9.
7. Thomas C, Oates PS. Ferroportin/IREG-1/MTP-1/ SLC40A1 modulates the uptake of iron at the apical membrane of enterocytes. Gut 2004; 53: 44-9.
8. Vulpe CD, Kuo YM, Murphy TL, et al. Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat Genet 1999; 21: 195-9.
9. Kuo YM, Su T, Chen H, et al. Mislocalisation of hephaestin, a multicopper ferroxidase involved in basolateral intestinal iron transport, in the sex linked anaemia mouse. Gut 2004; 53: 201-6.
10. Nittis T, Gitlin JD. Role of copper in the proteosome-mediated degradation of the multicopper oxidase hephaestin. J Biol Chem 2004; 279: 25696-702.
11. Xu X, Pin S, Gathinji M, Fuchs R, Harris ZL. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis. Ann N Y Acad Sci 2004; 1012: 299-305.
12. Stearman R, Yuan DS, Yamaguchi-Iwai Y, Klausner RD, Dancis A. A permease-oxidase complex involved in high-affinity iron uptake in yeast. Science 1996; 271: 1552-7.
13. Kuhn LC, Hentze MW. Coordination of cellular iron metabolism by post-transcriptional gene regulation. J Inorg Biochem 1992; 47: 183-95.
14. Liu XB, Hill P, Haile DJ. Role of the ferroportin iron-responsive element in iron and nitric oxide dependent gene regulation. Blood Cells Mol Dis 2002; 29: 315-26.
15. Lymboussaki A, Pignotti E, Montosi G, Garuti C, Haile DJ, Pietrangelo A. The role of the iron responsive element in the control of ferroportin1/IREG1/ MTP1 gene expression. J Hepatol 2003; 39: 710-5.
16. Knutson MD, Vofo MR, Haile DJ, Wessling-Resnick M. Iron loading and erythrophagocytosis increase ferroportin1 (FPN1) expression in J774 macrophages. Blood 2003; 102: 4191-7.
17. Chung J, Haile DJ, Wessling-Resnick M. Copper-induced ferroportin1 expression in J774 macrophages is associated with increased iron efflux. Proc Natl Acad Sci USA 2004; 101: 2700-5.
18. Nemath E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Gantz T, Kaplan J. Hepcidin regulates iron efflux by binding to ferroportin and inducing its internalization. Science 2004; 28: [e-pub ahead of print].
19. Beaumont C, Nicolas G, Vaulont S. L'Hepcidine, un régulateur majeur du métabolisme du fer. Hématologie 2003; 9: 27-36.
20. Pigeon C, Ilyin G, Caurselaud B, et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 2001; 276: 7811-9.
21. Nicolas G, Bennoun M, Devaux I, et al. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci USA 2001; 98: 8780-5.
22. Nicolas G, Bennoun M, Parteu A, et al. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci USA 2002; 99: 4596-601.
23. Roetto A, Papanikolaou G, Politou M, et al. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet 2003; 33: 21-2.
24. Nicolas G, Viatte L, Lau DQ, et al. Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis. Nat Genet 2003; 34: 97-101.
25. Mouhat S, Jouirou B, Mosbah A, De Waard M, Sabatier JM. Diversity of folds in animal toxins acting on ion channels. Biochem J 2004; 378: 717-26.
26. Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004; 113: 1271-6.
27. Yang F, Liu XB, Quinones M, Melby PC, Ghio A, Haile DJ. Regulation of reticuloendothelial iron transporter MTP1 (Slc11a3) by inflammation. J Biol Chem 2002; 277: 39786-91.
28. Frazer DM, Wilkins SJ, Becker EM, et al. Hepcidin expression inversely correlates with the expression of duodenal iron transporters and iron absorption in rats. Gastroenterology 2002; 123: 835-44.
29. Yamaji S, Sharp P, Ramesh B, Srai SK. Inhibition of iron transport across human intestinal epithelial cells by hepcidin. Blood 2004; 104: 2178-80.
30. Cardoso CS, De Sousa M. HFE, the MHC and hemochromatosis: paradigm for an extended function for MHC class I. Tissue Antigens 2003; 61: 263-75.
31. Papanikolaou G, Samuels ME, Ludwig EH, et al. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet 2004; 36: 77-82.
32. Pietrangelo A. Non-HFE hemochromatosis. Hepatology 2004; 39: 21-9.
33. Pietrangelo A, Montosi G, Totaro A, et al. Hereditary hemochromatosis in adults without pathogenic mutations in the hemochromatosis gene. N Engl J Med 1999; 341: 725-32.
34. Montosi G, Donovan A, Totaro A, et al. Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest 2001; 108: 619-23.
35. Njajou OT, De Jong G, Berghuis B, et al. Dominant hemochromatosis due to N144H mutation of SLC11A3: clinical and biological characteristics. Blood Cells Mol Dis 2002; 29: 439-43.
36. Gordeuk VR, Caleffi A, Corradini E, et al. Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroporrtn1) gene. Blood Cells Mol Dis 2003; 31: 299-304.
37. Beutler E, Bartan JC, Felitti VJ, et al. Ferroportin1 (SCL40A1) variant associated with iron overload in African-Americans. Blood Cells Mol Dis 2003; 31: 305-9.
38. Wallace DF, Clark RM, Harley HA, Subramaniam VN. Autosomal dominant iron overload due to a novel mutation of ferroportin1 associated with parenchymal iron loading and cirrhosis. J Hepatol 2004; 40: 710-3.
39. Rivard SR, Lanzara C, Grimard D, et al. Autosomal dominant reticuloendothelial iron overload (HFE type 4) due to a new missense mutation in the ferroportin1 gene (SLC11A3) in a large French-Canadian family. Haematologica 2003; 88: 824-6.
40. Devalia V, Carter K, Walker AP, et al. Autosomal dominant reticuloendothelial iron overload associated with a 3-base pair deletion in the ferroportin1 gene (SLC11A3). Blood 2002; 100: 695-7.
41. Wallace DF, Pedersen P, Dixon JL, et al. Novel mutation in ferroportin1 is associated with autosomal dominant hemochromatosis. Blood 2002; 100: 692-4.
42. Roetto A, Merryweather-Clarke AT, Daraio F, et al. A valine deletion of ferroportin1: a common mutation in hemochromastosis type 4. Blood 2002; 100: 733-4.
43. Cazzola M, Cremonesi L, Papaioannou M, et al. Genetic hyperferritinaemia and reticuloendothelial iron overload associated with a three base pair deletion in the coding region of the ferroportin gene (SLC11A3). Br J Haematol 2002; 119: 539-46.
44. Arden KE, Wallace DF, Dixon JL, et al. A novel mutation in ferroportin1 is associated with haemochromatosis in a Solomon Islands patient. Gut 2003; 52: 1215-7.
45. Hetet G, Devaux I, Soufir N, Grandchamp B, Beaumont C. Molecular analyses of patients with hyperferritinemia and normal serum iron values reveal both L ferritin IRE and 3 new ferroportin (slc11A3) mutations. Blood 2003; 102: 1904-10.
46. Beaumont C, Girelli D. Hereditary hyperferritinemia cataract syndrome. In: Templeton DM, ed. Molecular and cellular iron transport. New York: Marcel Dekker, 2002: 761-74.
47. Pietrangelo A. The ferroportin disease. Blood Cells Mol Dis 2004; 32: 131-8.
48. Jouanolle AM, Douabin-Gicquel V, Halimi C, et al. Novel mutation in ferroportin1 gene is associated with autosomal dominant iron overload. J Hepatol 2003; 39: 286-9.